New Phenomenex, Inc. Size Exclusion Columns for Biomolecules Deliver Significant Advancement in Resolving Power
Published: Jun 05, 2012
"We have worked with beta testers all over the globe and the feedback is overwhelmingly positive," said Kari Carlson Kelly, brand manager for Phenomenex. "Many of these users are already transferring their methods to Yarra."
Kieran Curley of Mannkind Corporation (Danbury, CT) is one of the early users of Yarra. "I was very impressed with the Yarra SEC-3000 300 x 7.8 mm column. It provided excellent resolution between the monomer and HMWP peaks, which allowed for consistent integration. The peak shape was greatly improved for all sample components," he said. "We immediately revised our test method to include the Yarra SEC-3000 column."
Yarra columns are highly reproducible, column-to-column and batch-to-batch, and Phenomenex's superior packing technology provides longer column life for time and money savings. The lifetime of Yarra columns can be further extended with the SecurityGuard column protection system. Phenomenex offers complete online application and method development and optimization support for the new product.
Phenomenex, celebrating its 30th anniversary in 2012, is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, clinical research, government and academic laboratories. From drug discovery and pharmaceutical development to food safety and environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being. For more information on Phenomenex, visit www.phenomenex.com or follow the company on Twitter @Phenomenex.